New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Novel insights into HBV-hepatocellular carcinoma at single-cell sequencing

Novel insights into HBV-hepatocellular carcinoma at single-cell sequencing

by Sichuan International Medical Exchange and Promotion AssociationThe intricate immune microenvironment, tumor cell plasticity, and dynamics of tumor evolution pose daunting challenges to the definit
Hepatobiliary&Pancreas Surgery January 26,2024
Novel insights into HBV-hepatocellular carcinoma at single-cell sequencing

Novel insights into HBV-hepatocellular carcinoma at single-cell sequencing

by Sichuan International Medical Exchange and Promotion AssociationThe intricate immune microenvironment, tumor cell plasticity, and dynamics of tumor evolution pose daunting challenges to the definit
Hepatobiliary&Pancreas Surgery January 26,2024
Unraveling the association between neonatal proteins and adult health

Unraveling the association between neonatal proteins and adult health

byUniversity of QueenslandGraphical abstract. Credit:Cell Genomics(2023). DOI: 10.1016/j.xgen.2023.100457Research led by Professor John McGrath from the University of Queensland foun
Pediatrics January 26,2024
Unraveling the association between neonatal proteins and adult health

Unraveling the association between neonatal proteins and adult health

byUniversity of QueenslandGraphical abstract. Credit:Cell Genomics(2023). DOI: 10.1016/j.xgen.2023.100457Research led by Professor John McGrath from the University of Queensland foun
Pediatrics January 26,2024
Study finds moderately elevated fracture risk following use of sedative–hypnotics

Study finds moderately elevated fracture risk following use of sedative–hypnotics

byThe University of Hong KongCredit: Unsplash/CC0 Public DomainGlobal consumption data show that there is an increasing trend of sedative–hypnotic prescriptions, especially in more developed aff
Breakthroughs January 26,2024
Study finds moderately elevated fracture risk following use of sedative–hypnotics

Study finds moderately elevated fracture risk following use of sedative–hypnotics

byThe University of Hong KongCredit: Unsplash/CC0 Public DomainGlobal consumption data show that there is an increasing trend of sedative–hypnotic prescriptions, especially in more developed aff
Breakthroughs January 26,2024
Mathematical dermatology: Unraveling the mechanism of urticaria from eruption shapes

Mathematical dermatology: Unraveling the mechanism of urticaria from eruption shapes

by Institute for the Advanced Study of Human Biology (ASHBI)In vivo pathophysiological network of chronic spontaneous urticaria (CSU). Credit:Communications Medicine(2023). DOI: 10.1038/s4
Immunology & Rheumatology January 26,2024
Mathematical dermatology: Unraveling the mechanism of urticaria from eruption shapes

Mathematical dermatology: Unraveling the mechanism of urticaria from eruption shapes

by Institute for the Advanced Study of Human Biology (ASHBI)In vivo pathophysiological network of chronic spontaneous urticaria (CSU). Credit:Communications Medicine(2023). DOI: 10.1038/s4
Immunology & Rheumatology January 26,2024
Popular blood thinner associated with higher risk of bleeding complications

Popular blood thinner associated with higher risk of bleeding complications

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainWhen diagnosed with a blood clot or atrial fibrillation, patients are often prescribed anticoagulants, or blood thinners, to prevent a fu
Breakthroughs January 26,2024
Popular blood thinner associated with higher risk of bleeding complications

Popular blood thinner associated with higher risk of bleeding complications

byUniversity of MichiganCredit: Pixabay/CC0 Public DomainWhen diagnosed with a blood clot or atrial fibrillation, patients are often prescribed anticoagulants, or blood thinners, to prevent a fu
Breakthroughs January 26,2024
Boosting immunotherapy in non-responsive cancer cells

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca
Oncology January 26,2024
Boosting immunotherapy in non-responsive cancer cells

Boosting immunotherapy in non-responsive cancer cells

by Surabhi Chandra,Indian Institute of ScienceAvik Chattopadhyay working in the lab. Credit: Nikita RamtekeCancer immunotherapy primes a patient's immune system to better find and destroy ca
Oncology January 26,2024
Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

by Anne Grimm,Leipzig UniversityCredit: Pixabay/CC0 Public DomainIn patients affected by myelodysplastic neoplasms, the body does not produce enough functional blood cells. Patients suffer from
Breakthroughs January 26,2024
Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

Clinical trial highlights possible treatment for anemia in myelodysplastic neoplasms

by Anne Grimm,Leipzig UniversityCredit: Pixabay/CC0 Public DomainIn patients affected by myelodysplastic neoplasms, the body does not produce enough functional blood cells. Patients suffer from
Breakthroughs January 26,2024
How an immune response is driven by one letter difference in DNA

How an immune response is driven by one letter difference in DNA

byRadboud UniversityA biphasic circuit regulates IL-1β and IL-37 expression to coordinate pro- and anti-inflammatory processes from within a single TAD. The two functionally opposed states of th
Immunology & Rheumatology January 26,2024
How an immune response is driven by one letter difference in DNA

How an immune response is driven by one letter difference in DNA

byRadboud UniversityA biphasic circuit regulates IL-1β and IL-37 expression to coordinate pro- and anti-inflammatory processes from within a single TAD. The two functionally opposed states of th
Immunology & Rheumatology January 26,2024
Mettl3-dependent m6A modification is essential for effector differentiation and memory formation of CD8+ T cells

Mettl3-dependent m6A modification is essential for effector differentiation and memory formation of CD8+ T cells

byScience China PressDuring viral infection, total m6A levels in Naïve stage, effector stage, and memory stage exhibit dynamic alteration (high-low-high). The presence of Mettl3 promotes CD8 T c
Immunology & Rheumatology January 26,2024
Mettl3-dependent m6A modification is essential for effector differentiation and memory formation of CD8+ T cells

Mettl3-dependent m6A modification is essential for effector differentiation and memory formation of CD8+ T cells

byScience China PressDuring viral infection, total m6A levels in Naïve stage, effector stage, and memory stage exhibit dynamic alteration (high-low-high). The presence of Mettl3 promotes CD8 T c
Immunology & Rheumatology January 26,2024
Five-day antibiotic course noninferior for pediatric febrile UTI

Five-day antibiotic course noninferior for pediatric febrile UTI

by Elana GotkineFor young children with febrile urinary tract infection (fUTI), a five-day amoxicillin-clavulanate course is noninferior to a 10-day course for recurrence of UTI within 30 days after c
Breakthroughs January 26,2024
Five-day antibiotic course noninferior for pediatric febrile UTI

Five-day antibiotic course noninferior for pediatric febrile UTI

by Elana GotkineFor young children with febrile urinary tract infection (fUTI), a five-day amoxicillin-clavulanate course is noninferior to a 10-day course for recurrence of UTI within 30 days after c
Breakthroughs January 26,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com